EFFECT OF EARLY USE OF METHYLENE BLUE AND VASOPRESSIN ON THE DOSE OF NORADRENALINE FOR MANAGEMENT OF SEPTIC SHOCK:A RANDOMIZED CONTROL STUDY - BLUE SHOCK

one0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年2月21日

试验速览

暂无简介。

•Patients older than 18 years diagnosed with septic shock during their ICU stay whose relatives give informed consent for the study will be considered for enrolment.
•Within 24hrs of septic shock

•Patients whose relatives refuse to give consent for the study.
•Unstable coronary artery syndrome (acute myocardial infarction during this episode of shock based on the combination of history, electrocardiogram and enzyme changes) or underlying cardiac dysfunction [cardiac index (CI) <2.2 l/min/m2]
•Stroke or head injury.
•Chronic renal failure on maintenance dialysis.
•Malignancy or other irreversible disease or condition for which mortality was estimated to be very high (defined by investigator),
•Acute mesenteric ischemia either proven or suspected
•Raynaudâ??s phenomenon
•Organ transplantation.
•Known hypersensitivity to norepinephrine or methylene blue -G 6PD deficiency.

发起方